Association of amino-terminal propeptide of type III procollagen and acute myocardial rejection in male patients receiving heart transplantation

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 8, 2007, Pages 1004-1008

  Lin, Yen Hung ^a   Liu, Chung Pin ^a,b   Hsu, Ron Bin ^a   Lee, Chi Ming ^a   Wang, Shoei Shen ^a   Kao, Hsien Li ^a   Chao, Chia Lun ^a   Shiau, Yu Chien ^c   Hung, Chi Sheng ^a   Liao, Lin Chu ^a   Ho, Yi Lwun ^a,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b YUAN'S GENERAL HOSPITAL   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Amino terminal propeptide of type I procollagen; Amino terminal propeptide of type III procollagen; Heart transplantation; Rejection

Indexed keywords

AMINOPEPTIDASE; AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT RECIPIENT; HEART CATHETERIZATION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROCOLLAGEN; PROGNOSIS;

EID: 34548808108     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.196     Document Type: Article

References (30)

1. Massad MG. Current trends in heart transplantation. Cardiology 2004;101:79-92.
2. Garrity ER Jr, Mehra MR. An update on clinical outcomes in heart and lung transplantation. Transplantation 2004;77:S68-74.
3. Ballester M, Bordes R, Tazelaar HD, Carrió I, Marrugat J, Narula J, et al. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging. J Am Coll Cardiol 1998;31:1357-61.
4. Teppo AM, Tornroth T, Honkanen E, Gronhagen-Riska C. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients. Transplantation 2003:75:2113-9.
5. Risteli J, Risteli L. Analysing connective tissue metabolites in human serum: biochemical, physiological and methodological aspects. J Hepatol 1995;22(Suppl 2):77-81.
6. Host NB, Aldershvile J, Horslev-Petersen K, Hoyer S, Haunso S. Serum aminoterminal propeptide of type III procollagen after cardiac transplantation and the effect of rejection. Am J Cardiol 1996;78:1406-10.
7. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transpl 1990;9:587-93.
8. Hsu RB, Chu SH, Wang SS, Ko WJ, Chou NK, Lee CM, et al. Low incidence of transplant coronary artery disease in Chinese heart recipients. J Am Coll Cardiol 1993;33:1573-77.
9. Ko WJ, Chou NK, Chen YS, Hsu RB, Wang SS, Chu SH. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506. Transplant Proc 1998;30:3339-41.
10. Lin YH, Ho YL, Wang TD, Lin LC, Wu CC, Ho YL, et al. The relation of aminoterminal propeptide of type III procollagen and severity of coronary artery disease in patients without myocardial infarction or hibernation. Clin Biochem 2006;39:861-6.
11. Lin YH, Shiau YC, Yen RF, Lin LC, Wu CC, Ho YL, et al. The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients. Ultrasound Med Biol 2004;30:885-91.
12. Baim DS. Coronary angiography. In: Baim DS, editor. Grossman's cardiac catheterization, angiography, and intervention, 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2006:187-221.
13. Baughman KL, Baim DS. Endomyocardial biopsy. In: Baim DS, editor. Grossman's cardiac catheterization, angiography, and intervention, 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2006:396-411.
14. Pickering JG, Boughner DR. Fibrosis in the transplanted heart and its relation to donor ischemic time. Assessment with polarized light microscopy and digital image analysis. Circulation 1990;81:949-58.
15. Tazelaar HD, Gay RE, Rowan RA, Billingham ME, Gay S. Collagen profile in the transplanted heart. Hum Pathol 1990;21:424-8.
16. Pardo Mindan FJ, Panizo A, Lozano MD, Herreros J, Mejia S. Role of endomyocardial biopsy in the diagnosis of chronic rejection in human heart transplantation. Clin Transplant 1997;11:426-31.
17. Uusimaa P, Risteli J, Niemelä M, Lumme J, Ikaheimo M, Jounela A, et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 1997;96:2565-72.
18. Poulsen SH, Host NB, Jensen SE. Relationship between serum amino-terminal propeptide of type III procollagen and change of left ventricular function after acute myocardial infarction. Circulation 2000;102:1527-32.
19. Bonnet J, Garderes PE, Aumailley M, Moreau C, Gouverneur G, Benchimol D, et al. Serum type III procollagen peptide levels in coronary artery disease (a marker of atherosclerosis). Eur J Clin Invest 1988;18:18-21.
20. Lombardi R, Betocchi S, Losi MA, Tocchetti CG, Aversa M, Miranda M, et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 2003;108:1455-60.
21. Nakashima H, Sugiura H, Nishida Y, Yamada Y, Tabata Y, Ishiguro N. Stimulated type I collagen turnover in patients with giant cell tumor of bone. Calcif Tissue Int 2003;73:5-8.
22. Saarela T, Risteli J, Koivisto M. Effects of short-term dexamethasone treatment on collagen synthesis and degradation markers in preterm infants with developing lung disease. Acta Paediatr 2003;92:588-94.
23. Crofton PM, Shrivastava A, Wade JC, Stephen R, Kelnar CJ, McIntosh N, et al. Effects of dexamethasone treatment on bone and collagen turnover in preterm infants with chronic lung disease. Pediatr Res 2000;48:155-62.
24. Crowley S, Trivedi P, Risteli L, Risteli J, Hindmarsh PC, Brook CG. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr 1998;132:409-13.
25. Oikarinen A. Effect of cortisol acetate on collagen biosynthesis and on the activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in chick-embryo tendon cells. Biochem J 1977;164:533-9.
26. Risteli J. Effect of prednisolone on the activities of the intracellular enzymes of collagen biosynthesis in rat liver and skin. Biochem Pharmacol 1977;26:1295-8.
27. Du XJ, Samuel CS, Gao XM, Zhao L, Parry LJ, Tregear GW. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res 2003;57:395-404.
28. Jorgensen LN, Sorensen LT, Kallehave F, Vange J, Gottrup F. Premenopausal women deposit more collagen than men during healing of an experimental wound. Surgery 2002;131:338-43.
29. Crofton PM, Wade JC, Taylor MR, Holland CV. Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in school children. Clin Chem 1997;43:1577-81.
30. Wreje U, Brynhildsen J, Aberg H, Bystrom B, Hammar M, von Schoultz B. Collagen metabolism markers as a reflection of bone and soft tissue turnover during the menstrual cycle and oral contraceptive use. Contraception 2000;61:265-70.